This group covers vascular (arterial, venous, and lymphatic ) damages clustered in families.
| 1. |
None (2006) Potential new risk factors for ischemic stroke: what is their potential?
|
| 2. |
Uhlmann K et al. (2006) Genetics of diabetic retinopathy.
|
| 3. |
None (2006) The interaction between pathogens and the host coagulation system.
|
| 4. |
Mahr AD et al. () Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants.
|
| 5. |
Dashti SR et al. (2006) Molecular genetics of familial cerebral cavernous malformations.
|
| 6. |
Bhoday J et al. (2006) The molecular mechanisms of vascular restenosis: Which genes are crucial?
|
| 7. |
Weiler CR et al. (2006) Genetic test indications and interpretations in patients with hereditary angioedema.
|
| 8. |
Orlacchio A et al. () Research actuality in the genetics of stroke.
|
| 9. |
Kim SH et al. (2006) Genetic mechanism of aspirin-induced urticaria/angioedema.
|
| 10. |
Nguyen T et al. () Variability of response to clopidogrel: possible mechanisms and clinical implications.
|
| 11. |
Szolnoki Z et al. (2006) Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis.
|
| 12. |
None (2006) The molecular biology of thrombotic microangiopathy.
|
| 13. |
Krischek B et al. (2006) The genetics of intracranial aneurysms.
|
| 14. |
Nordlie MA et al. (2006) Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy.
|
| 15. |
None (2006) The genetics of heart attack.
|
| 16. |
None (2006) Contribution of angiogenic genes to the complex genetic trait underlying Kawasaki disease.
|
| 17. |
Zambon A et al. (2006) Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
|